The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics?
Authors:
Open Access
- 1 January 2013
- journal article
- Published by Medknow in Dental Research Journal
- Vol. 10 (2) , 143-8
Abstract
Periodontal disease is a chronic inflammatory disease which represents a primarily anaerobic Gram-negative oral infection that results in gingival inflammation, loss of attachment, bone destruction. Bacterial endotoxins in the form of lipopolysaccharides (LPS) that are instrumental in generating a host-mediated tissue destructive immune response by mobilizing their defensive cells and releasing cytokines like Interleukin-1β (IL-1β), Tumor Necrosis Factor-α (TNF-α), and Interleukin-6 (IL-6), which lead to tissue destruction by stimulating the production of the collagenolytic enzymes: Matrix metalloproteinases (MMPs). Since the host-mediated tissue destruction is to be controlled, various means have been employed for modulating this response. Statins, 3-hydroxy-3-methylglutarylcoenzyme A (HMG CoA) reductase inhibitors, besides having lipid-lowering abilities also have antioxidant, antithrombotic, anti-inflammatory, immunomodulatory and osteomodulatory properties. All of these pleiotropic effects of statins point out to it perhaps becoming the novel host modulation agent in periodontics.Keywords
This publication has 52 references indexed in Scilit:
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- Simvastatin Versus EzetimibeCirculation, 2005
- Chemical, pharmacokinetic and pharmacodynamic properties of statins: an updateFundamental & Clinical Pharmacology, 2004
- Inflammation, Immunity, and HMG-CoA Reductase InhibitorsCirculation, 2004
- Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cellsJournal of Cellular Biochemistry, 2004
- Periodontal Host Modulation with Antiproteinase, Anti‐Inflammatory, and Bone‐Sparing Agents. A Systematic ReviewAnnals of Periodontology, 2003
- Perspective of Cytokine Regulation for Periodontal Treatment: Fibroblast BiologyJournal of Periodontology, 2003
- HMG-CoA Reductase Inhibitors and the Risk of FracturesJAMA, 2000
- Non-lipid-related effects of statinsAnnals of Medicine, 2000
- PeriodontitisAnnals of Periodontology, 1999